Showing results (211-220 of 12,926) with videos related to
Sort By:
Pageof 1,293
Lancet (London, England)|August 31, 2010
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysisJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.The Annals of Thoracic Surgery|September 1, 1989
It will work: the first successful mitral valve replacementN S BraunwaldJournal of the American College of Cardiology|February 11, 1999
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 StudyR C Becker, J S Hochman, C P Cannon, et al.Circulation|October 25, 2000
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudyD A Morrow, E M Antman, A Charlesworth, et al.The American Journal of Cardiology|November 15, 2000
ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigatorsJ A de Lemos, E M Antman, R P Giugliano, et al.Lancet (London, England)|November 22, 2001
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudyD A Morrow, E M Antman, R P Giugliano, et al.Journal of Clinical Pharmacology|May 12, 2000
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarctionN B Modi, N L Fox, F W Clow, et al.The American Journal of Cardiology|September 8, 2001
The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarctionP F Bray, C P Cannon, P Goldschmidt-Clermont, et al.The American Journal of Cardiology|August 25, 2004
Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy)C Michael Gibson, Kanwar P Singh, Sabina A Murphy, et al.The American Journal of Cardiology|November 25, 2000
Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-IIJ A de Lemos, E M Antman, R P Giugliano, et al.Pageof 1,293